Performant Healthcare, Inc. (PHLT)
NASDAQ: PHLT · Real-Time Price · USD
7.64
+4.09 (115.21%)
At close: Aug 1, 2025, 4:00 PM
7.57
-0.07 (-0.92%)
After-hours: Aug 1, 2025, 7:58 PM EDT

Performant Healthcare Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Performant Healthcare stock has a target of 8.00, which predicts a 4.71% increase from the current stock price of 7.64.

Price Target: $8.00 (+4.71%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$8.00$8.00$8.00$8.00
Change+4.71%+4.71%+4.71%+4.71%

Analyst Ratings

According to 1 stock analyst, the rating for Performant Healthcare is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingJul '25
Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0
Total1

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
JMP Securities
JMP Securities
Buy
Initiates
$8
BuyInitiates$8+4.71%Jul 10, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
136.50M
from 122.98M
Increased by 10.99%
Revenue Next Year
152.16M
from 136.50M
Increased by 11.47%
EPS This Year
0.02
from -0.13
EPS Next Year
0.12
from 0.02
Increased by 666.67%
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
155.94M124.39M109.18M113.74M122.98M136.50M152.16M172.38M
Revenue Growth
3.66%-20.23%-12.23%4.18%8.12%10.99%11.47%13.29%
EPS
-0.26-0.17-0.09-0.10-0.130.020.12-
EPS Growth
------666.67%-
Forward PE
-----499.3565.13-
No. Analysts
-----553
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027
High140.9M158.7M177.5M
Avg136.5M152.2M172.4M
Low130.7M143.7M165.6M

Revenue Growth

Revenue Growth202520262027
High
14.6%
16.2%
16.6%
Avg
11.0%
11.5%
13.3%
Low
6.3%
5.3%
8.8%

EPS Forecast

EPS20252026
High0.030.17
Avg0.020.12
Low-0.07

EPS Growth

EPS Growth20252026
High-
998.0%
Avg-
666.7%
Low-
348.4%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.